We are live on ! Find out more
TGV

TRV GP V Portfolio holdings

AUM $401M
1-Year Est. Return 284.76%
This Fund
S&P 500
This Quarter Est. Return
-53.01%
1 Year Est. Return
+284.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$169M
Cap. Flow
+$11.4M
Cap. Flow %
9.15%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$11.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPP
1
Rapport Therapeutics
RAPP
$2.01B
$71.6M 57.21%
7,135,233
– –
SEPN
2
Septerna Inc
SEPN
$1.51B
$36M 28.77%
6,215,591
– –
MAZE
3
Maze Therapeutics
MAZE
$1.59B
$10.5M 8.37%
+950,800
New +$11.4M
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
$7.07M 5.65%
1,737,216
– –

Similar funds

SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
BLC
Brown, Lisle/Cummings Providence, Rhode Island $400M AUM 18.79% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
BWA
Beam Wealth Advisors Covington, Louisiana $402M AUM 20.08% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $402M AUM 10.33% 1-Year Est. Return
MM
Meridian Management Little Rock, Arkansas $402M AUM 17.05% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return

TRV GP V's Q1 2025 Portfolio in Review

As of Q1 2025, TRV GP V held 4 positions worth $125M, down 57% from $294M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP V deployed $11.4M of net new capital in Q1 2025, opening 1 new position. Its largest new stake was Maze Therapeutics: 950,800 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP V's largest Q1 2025 buy was Maze Therapeutics: 950,800 shares worth $10.5M.
  • TRV GP V's ten largest holdings make up 100% of its $125M portfolio in Q1 2025.
  • TRV GP V opened 1 new position and closed 0 in Q1 2025.
  • TRV GP V's portfolio value fell 57% quarter-over-quarter to $125M.

Based on TRV GP V's 13F filing for Q1 2025, filed 9 May 2025.